DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Dreesen E, Verstockt B, Bian S. et al.
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol 2018 S1542-3565(18)30402-6
Access:
We do not assume any responsibility for the contents of the web pages of other providers.